Gufic Biosciences Limited (GUFICBIO.NS) Valuation

Valuation

Model-based estimates, not advice. The DCF is the discounted-cash-flow value per share; compare it with the price, not as a target.

DCF fair value

-117.2%

-₹71.54

vs ₹415.10 price

Levered DCF

-₹541.05

After debt service

Piotroski score

6 / 9

Average

Altman Z-score

—

Rating

C-

Overall 1 / 5

Ratios by fiscal year

Margins and yields are shares of revenue, equity or price; multiples are ×.

Metric	FY2026	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019
P/E	42.78×	48.63×	33.32×	22.68×	25.18×	25.11×	20.45×	28.58×
P/B	4.13×	5.63×	5.39×	5.2×	8.97×	6.4×	3.59×	8.33×
P/S	2.91×	4.13×	3.56×	2.62×	3.1×	2.28×	1.22×	1.79×
EV / EBITDA	19.97×	26.7×	21.62×	15.4×	16.41×	13.58×	10.34×	14.42×
Gross margin	36.0%	36.2%	50.5%	50.9%	45.7%	47.4%	26.8%	26.6%
Operating margin	12.8%	13.9%	35.9%	36.5%	16.6%	14.0%	10.2%	11.8%
Net margin	6.8%	8.5%	10.7%	11.5%	12.3%	9.1%	6.0%	6.3%
Current ratio	1.55×	1.61×	1.61×	1.61×	1.72×	1.59×	1.14×	1.25×
Debt / equity	0.61×	0.56×	0.63×	0.96×	0.24×	0.35×	0.98×	1.3×
Interest coverage	3.29×	4.92×	18.84×	30.66×	37.02×	5×	2.77×	4.59×
Dividend yield	0.0%	0.0%	0.0%	0.1%	0.0%	0.0%	0.1%	0.1%
Payout ratio	1.6%	1.4%	1.1%	1.3%	1.0%	0.8%	2.1%	1.8%

Key metrics by fiscal year

Metric	FY2026	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019
Return on equity	9.7%	11.6%	16.2%	22.9%	35.6%	25.5%	17.5%	29.1%
Return on invested capital	8.1%	8.7%	24.3%	26.9%	27.8%	20.8%	10.8%	14.3%
Return on assets	4.8%	6.0%	7.9%	9.3%	18.4%	11.3%	5.6%	7.8%
Free cash flow yield	-0.7%	0.8%	-4.2%	-11.9%	0.8%	6.7%	1.6%	-1.3%
Earnings yield	2.3%	2.1%	3.0%	4.4%	4.0%	4.0%	4.9%	3.5%
Enterprise value	₹30.8B	₹36.9B	₹32B	₹21.1B	₹24.7B	₹11.7B	₹5.9B	₹7.2B
Net debt / EBITDA	2.13×	2.22×	2.24×	2.23×	0.35×	0.65×	2.15×	1.88×
Cash conversion cycle (days)	191	181	181	166	49	69	110	131